- Trials with a EudraCT protocol (1)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
1 result(s) found for: 2007-000371-42.
Displaying page 1 of 1.
EudraCT Number: 2007-000371-42 | Sponsor Protocol Number: 3066K1-139-US | Start Date*: 2007-09-20 | |||||||||||||||||||||
Sponsor Name:Wyeth Research Division of Wyeth Pharmaeuticals Inc. | |||||||||||||||||||||||
Full Title: A Phase I/II Safety and Exploratory Pharmacodynamic Study of Intravenous Temsirolimus (CCI-779) in Pediatric Subjects with Relapsed/Refractory Solid Tumors | |||||||||||||||||||||||
Medical condition: Relapsed/refractory neuroblastoma,high-grade glioma, and rhabdomyosarcoma. | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Infants and toddlers, Children, Adolescents, Under 18, Adults | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: FR (Completed) DE (Completed) PL (Completed) | |||||||||||||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
